Articles | Earlham Institute

FEATURE | 15 min READ

How single-cell genomics can foil drug-resistant cancer

PhD student Silvia Ogbeide explains how she’s using the latest single-cell sequencing technologies to track drug resistance in cancer.

Sorry, no articles match the selected filters.

Our research
- Research strategy
  - Our Culture
  - Open and FAIR Data
- Explore our research
  - Research projects
  - Publications
- Our research programmes
- National Bioscience Research Infrastructures
  - Earlham Biofoundry
  - Transformative Genomics
- Scientific Groups
Technology platforms
Training and events
Stories and impact
About
People
- Staff
Careers
Contact